These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6371541)

  • 1. Strain differentiation of pathogenic yeasts by the killer system.
    Morace G; Archibusacci C; Sestito M; Polonelli L
    Mycopathologia; 1984 Feb; 84(2-3):81-5. PubMed ID: 6371541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High incidence of sensitivity to yeast killer toxins among Candida and Torulopsis isolates of human origin.
    Middelbeek EJ; Hermans JM; Stumm C; Muytjens HL
    Antimicrob Agents Chemother; 1980 Mar; 17(3):350-4. PubMed ID: 7191690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Killer system: a simple method for differentiating Candida albicans strains.
    Polonelli L; Archibusacci C; Sestito M; Morace G
    J Clin Microbiol; 1983 May; 17(5):774-80. PubMed ID: 6345575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rapid identification and susceptibility to killer toxins of yeasts isolated from non-systemic mycoses].
    Sangorrín MP; Lopes CA; Rivero A; Caballero AC
    Rev Argent Microbiol; 2007; 39(4):230-6. PubMed ID: 18390160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital.
    Posteraro B; Spanu T; Fiori B; De Maio F; De Carolis E; Giaquinto A; Prete V; De Angelis G; Torelli R; D'Inzeo T; Vella A; De Luca A; Tumbarello M; Ricciardi W; Sanguinetti M
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3944-55. PubMed ID: 25896705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Killer phenomenon in pathogenic yeast.
    Kandel JS; Stern TA
    Antimicrob Agents Chemother; 1979 Apr; 15(4):568-71. PubMed ID: 572656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An emerging issue of mixed yeast cultures.
    Yang YL; Chu WL; Lin CC; Tsai SH; Chang TP; Lo HJ
    J Microbiol Immunol Infect; 2014 Aug; 47(4):339-44. PubMed ID: 23523053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts.
    Quindós G; Ruesga MT; Martín-Mazuelos E; Salesa R; Alonso-Vargas R; Carrillo-Muñoz AJ; Brena S; San Millán R; Pontón J
    Rev Iberoam Micol; 2004 Jun; 21(2):63-9. PubMed ID: 15538829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of two commercialized systems for the rapid identification of medically important yeasts.
    Quindós G; Lipperheide V; Pontón J
    Mycoses; 1993; 36(9-10):299-303. PubMed ID: 8015561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Killer activity of yeasts isolated from natural environments against some medically important Candida species.
    Vadkertiová R; Sláviková E
    Pol J Microbiol; 2007; 56(1):39-43. PubMed ID: 17419188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the killer toxin of several yeasts and the purification of a toxin of type K2.
    Pfeiffer P; Radler F
    Arch Microbiol; 1984 Apr; 137(4):357-61. PubMed ID: 6375620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the new Mycotube test-kit for yeast identification.
    Guinet RM
    Eur J Clin Microbiol; 1985 Feb; 4(1):10-3. PubMed ID: 3886377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large-scale screening of selected Candida maltosa, Debaryomyces hansenii and Pichia anomala killer toxin activity against pathogenic yeasts.
    Buzzini P; Martini A
    Med Mycol; 2001 Dec; 39(6):479-82. PubMed ID: 11798052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Killer toxins of certain yeast strains have potential growth inhibitory activity on gram-positive pathogenic bacteria.
    Izgü F; Altinbay D
    Microbios; 1997; 89(358):15-22. PubMed ID: 9218351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Pro-Lab ID ring system for the identification of medically important yeasts.
    Sekhon AS; Padhye AA; Garg AK; Rae R
    Mycopathologia; 1992 Jul; 119(1):11-6. PubMed ID: 1406902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isavuconazole MIC distribution of 29 yeast species responsible for invasive infections (2015-2017).
    Desnos-Ollivier M; Bretagne S; Boullié A; Gautier C; Dromer F; Lortholary O;
    Clin Microbiol Infect; 2019 May; 25(5):634.e1-634.e4. PubMed ID: 30771532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the killer character in different yeasts and its classification.
    Young TW; Yagiu M
    Antonie Van Leeuwenhoek; 1978; 44(1):59-77. PubMed ID: 655699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of yeasts from clinical specimens by oxidase test.
    Kumar S; Arora BS; Mathur MD
    Indian J Pathol Microbiol; 2000 Oct; 43(4):429-31. PubMed ID: 11344606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New and emerging yeast pathogens.
    Hazen KC
    Clin Microbiol Rev; 1995 Oct; 8(4):462-78. PubMed ID: 8665465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between killer yeasts and pathogenic fungi.
    Walker GM; McLeod AH; Hodgson VJ
    FEMS Microbiol Lett; 1995 Apr; 127(3):213-22. PubMed ID: 7758935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.